US72940R3003 - PSTI - A2PPB4 (XNMS)
PLURISTEM THERAPEUTICSCS INC Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -76,39 % |
Firmenprofil zu PLURISTEM THERAPEUTICSCS INC Aktie
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.
Unternehmensdaten zur PLURISTEM THERAPEUTICSCS INC Aktie
Name PLURISTEM THERAPEUTICSCS INC
Firma Pluristem Therapeutics Inc.
Symbol PSTI
Website https://www.pluristem.com
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A2PPB4
ISIN US72940R3003
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Yaky Yanay
Marktkapitalisierung 41 Mio
Land Israel
Währung USD
Mitarbeiter 0,2 T
Adresse Matam Advanced Technology Park, Building No. 5, 3508409 Haifa
IPO Datum 2007-12-10
Aktien-Splits
Datum | Split |
---|---|
25.07.2019 | 1:10 |
26.11.2007 | 1:200 |
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
28.12.2007 | PLRS | PSTI |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | PSTI |
Weitere Aktien
Investoren die PLURISTEM THERAPEUTICSCS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024